Showing results (2391-2400 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|January 18, 2011
New agents and approaches to treatment in Niemann-Pick type C diseaseMaría S Pérez-Poyato, Mercé PinedaCurrent Pharmaceutical Biotechnology|January 18, 2011
Treatment of fabry disease: current and emerging strategiesPaula Rozenfeld, Pablo M NeumannCurrent Pharmaceutical Biotechnology|January 18, 2011
The role of brain gaseous transmitters in the regulation of the circulatory systemMarcin Ufnal, Mariusz SikoraCurrent Pharmaceutical Biotechnology|January 18, 2011
Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitusAndi Masha, Stefano Dinatale, Stefano Allasia, et al.Current Pharmaceutical Biotechnology|January 18, 2011
Old and new gasotransmitters in the cardiovascular system: focus on the role of nitric oxide and hydrogen sulfide in endothelial cells and cardiomyocytesDaniele Mancardi, Alessandra Florio Pla, Francesco Moccia, et al.Current Pharmaceutical Biotechnology|January 18, 2011
Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor moleculeIstván Hornyák, Eszter Pankotai, Levente Kiss, et al.Current Pharmaceutical Biotechnology|January 18, 2011
Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosisDavide Grassi, Giovambattista Desideri, Claudio FerriCurrent Pharmaceutical Biotechnology|September 3, 2010
Structure based design of 11β-HSD1 inhibitorsSuresh Singh, Colin TiceCurrent Pharmaceutical Biotechnology|October 14, 2010
Anti-angiogenesis drugs in diabetic retinopathyV Swetha E JeganathanCurrent Pharmaceutical Biotechnology|October 14, 2010
Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathySho-ichi Yamagishi, Takanori MatsuiPageof 303